Atrial fibrillation trials in Hungary
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Budapest VIII, Nyíregyháza, Szekszárd, Szolnok
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Balatonfured, Békéscsaba, Budapest, Budapest II, Budapest III, Budapest VIII, Budapest XII, Budapest XIII, Debrecen, Hódmezővásárhely, Kecskemét, Kistarcsa, Nyíregyháza, Orosháza, Pecs, Pécs, Szeged, Székesfehérvár, Szekszárd, Szolnok, Zalaegerszeg
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 2Taking peopleA Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
- Where
- Budapest XII, Szekszárd
- Age
- 18 years to 85 years
- People
- 360 worldwide
- Run by
- Bayer
See details and how to joinNCT07625215 · EU 2025-523807-31-00 - Phase 2Taking peopleClinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
- Where
- Budapest, Budapest II, Budapest XII, Budapest XIII, Pécs, Sopron, Szeged, Szolnok, Tatabánya, Zalaegerszeg
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Acesion Pharma
See details and how to joinNCT07267949 · EU 2025-521377-14-00 - No phaseTaking peopleIntracardiac Echocardiography-guided Versus Electroanatomical Mapping-guided Pulsed Field Ablation for Paroxysmal Atrial Fibrillation
- Where
- Budapest
- Age
- 18 years and over
- People
- 292 worldwide
- Run by
- Mitera Hospital
See details and how to joinNCT07772518 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Békéscsaba, Budapest, Budapest III, Budapest VIII, Budapest XIII, Budapest XVIII, Gyongyos, Kaposvár, Kistarcsa, Nyíregyháza, Pécs, Szeged, Veszprém, Zalaegerszeg
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - Phase 4Taking peopleThe Role of Beta-Blockade During Cardiac CT in Patients with Atrial Fibrillation
- Where
- Budapest XII
- Age
- 18 years and over
- People
- 136
- Run by
- Semmelweis University
See details and how to join2025-523391-22-01 · EU 2025-523391-22-01 - No phaseTaking peopleAtrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
- Where
- Budapest
- Age
- 60 years and over
- People
- 220 worldwide
- Run by
- University Hospital, Geneva
See details and how to joinNCT06207383 - No phaseTaking peopleThe Role of Multimodality Imaging in Left Atrial Appendage Closure
- Where
- Budapest
- Age
- 18 years and over
- People
- 44
- Run by
- Hungarian Institute of Cardiology
See details and how to joinNCT04800913 - Phase 3Not yet taking people in HungaryFirst-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation
- Where
- Pécs
- Age
- 18 years to 75 years
- People
- 220 worldwide
- Run by
- Region Örebro County
See details and how to joinNCT05939076 · EU 2023-505962-28-00